Cargando…

Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma

OBJECTIVE: The aim of this study was to construct the immunoscore (IS) to facilitate the prediction of postoperative survival and benefit from adjuvant chemotherapy (ACT) in esophageal squamous cell carcinoma (ESCC). METHODS: A total of 249 patients who received radical esophagectomy at Fudan Univer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuge, Lingdun, Huang, Binhao, Xie, Juntao, Gao, Zhendong, Zheng, Difan, Zheng, Shanbo, Xiang, Jiaqing, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751312/ https://www.ncbi.nlm.nih.gov/pubmed/33364836 http://dx.doi.org/10.2147/CMAR.S279684

Ejemplares similares

Preoperative brain MRI for clinical stage IA lung cancer: is routine scanning rational?
por: Zhuge, Lingdun, et al.
Publicado: (2018)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer
por: Cheng, Chao, et al.
Publicado: (2022)

Immunoscore Signatures in Surgical Specimens and Tumor-Infiltrating Lymphocytes in Pretreatment Biopsy Predict Treatment Efficacy and Survival in Esophageal Cancer
por: Noma, Toshiki, et al.
Publicado: (2023)

A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer
por: Jiang, Wei, et al.
Publicado: (2023)

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis
por: Wang, Yun, et al.
Publicado: (2021)

Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature
por: Asselta, Rosanna, et al.
Publicado: (2021)

Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2021)

Endoscopic resection with adjuvant treatment versus esophagectomy for early-stage esophageal cancer
por: Huang, Binhao, et al.
Publicado: (2021)

Clinical and genetic features of lung squamous cell cancer in never-smokers
por: Huang, Yangle, et al.
Publicado: (2016)

SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas
por: Zheng, Shanbo, et al.
Publicado: (2015)

Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta‐analysis
por: Zhao, Peiliang, et al.
Publicado: (2018)

A novel model based on liquid‐liquid phase separation–Related genes correlates immune microenvironment profiles and predicts prognosis of lung squamous cell carcinoma
por: Zhuge, Lingdun, et al.
Publicado: (2021)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Chen, Mingqiu, et al.
Publicado: (2018)

Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
por: Wang, Jie, et al.
Publicado: (2018)

From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors
por: Wei, Miaoyan, et al.
Publicado: (2021)

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
por: Galon, Jérôme, et al.
Publicado: (2014)

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
por: Sun, Jong-Mu
Publicado: (2020)

Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
por: Meng, Jin, et al.
Publicado: (2018)

Study on chemotherapeutic sensitizing effect of nimotuzumab on different human esophageal squamous carcinoma cells
por: YANG, XIAOYU, et al.
Publicado: (2016)

Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer
por: Jiang, Yuming, et al.
Publicado: (2018)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Immunoscore: a new possible approach for melanoma classification
por: Capone, Mariaelena, et al.
Publicado: (2014)

Biomarkers immune monitoring technology primer: Immunoscore® Colon
por: Hermitte, Fabienne
Publicado: (2016)

Immunoscore in mismatch repair‐proficient and ‐deficient colon cancer
por: Wirta, Erkki‐Ville, et al.
Publicado: (2017)

Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma
por: Guo, Congfang, et al.
Publicado: (2019)

Usefulness and robustness of Immunoscore for personalized management of cancer patients
por: Marliot, Florence, et al.
Publicado: (2020)

Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma
por: Li, Yanyan, et al.
Publicado: (2020)

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
por: Nassif, Elise F., et al.
Publicado: (2021)

An immunoscore nomogram for predicting survival in patients with oesophageal cancer
por: Li, Gaoming, et al.
Publicado: (2021)

Prognostic significance of immunoscore related markers in bladder cancer
por: Ariafar, Ali, et al.
Publicado: (2022)

Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
por: Willis, Joseph, et al.
Publicado: (2023)

Integrated analysis of optical mapping and whole-genome sequencing reveals intratumoral genetic heterogeneity in metastatic lung squamous cell carcinoma
por: Peng, Yizhou, et al.
Publicado: (2020)

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma
por: Yang, Yuchong, et al.
Publicado: (2019)

Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma
por: Zheng, Bohao, et al.
Publicado: (2023)

Postoperative follow-up strategy based on event dynamics for esophageal squamous cell carcinoma
por: Zhang, Yongcong, et al.
Publicado: (2021)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
por: Chen, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ocb737711r1j2k3fbva80hib7